- Home
- GMEX vs BDRX Comparison
GMEX vs BDRX Comparison
Compare GMEX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMEX | BDRX |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | Australia | United Kingdom |
| Employees | 16 | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.0M |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GMEX | BDRX |
|---|---|---|
| Price | $1.93 | $3.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 182.7K |
| Earning Date | 04-17-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.60 |
| 52 Week High | $2.50 | $11.88 |
Technical Indicators
Market Signals| Indicator | GMEX | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 49.13 |
| Support Level | $1.44 | $2.97 |
| Resistance Level | $2.10 | $4.39 |
| Average True Range (ATR) | 0.30 | 0.39 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 44.18 | 10.59 |
Price Performance
Historical ComparisonAbout GMEX GMEX ROBOTICS CORPORATION Class A Ordinary Shares
GMEX Robotics Corp is engaged in the design and deployment of AI-powered robotics and intelligent consumer technologies. The group operates in three business areas: Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity; AI-Driven Hardware: Embedding artificial intelligence into physical products to create self-learning and adaptive user experiences; and Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.